Lv3
315 积分 2021-10-07 加入
Bronchodilator reversibility, body-plethysmographic phenotypes, and mortality in patients with COPD or PRISm
1个月前
已关闭
Long-Term Outcomes Associated with the Super-Exacerbator Phenotype after a Hospitalization for COPD
1个月前
已完结
Associations between life-course FEV1/FVC trajectories and respiratory symptoms up to middle age: analysis of data from two prospective cohort studies
2个月前
已完结
A multi-country cohort study evaluating the prevalence, risk factors, lung function and clinical outcomes of chronic bronchitis in low- and middle-income countries
2个月前
已关闭
Type 2 inflammatory biomarkers in asthma and COPD: what we think we know
2个月前
已关闭
Pre-COPD: an evolving concept with practice potential
2个月前
已完结
Neutrophil-to-Lymphocyte Ratio (NLR) as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS cohort
3个月前
已完结
The Association of Interstitial Lung Abnormalities and Preserved Ratio Impaired Spirometry (PRISm) with Mortality
3个月前
已完结
Absolute benefit measures are essential for guiding therapies in COPD in an era of precision medicine: a viewpoint on “number needed to treat”
3个月前
已完结
Reduction in sputum inflammatory cells after a single dose of cepeprubart in COPD patients
3个月前
已完结
皖公网安备34019202002308
